SDB-006

SDB-006

Legal status
Legal status	CA: Schedule II DE: Anlage II (Authorized trade only, not prescriptible)
Identifiers
IUPAC name N-benzyl-1-pentyl-1H-indole-3-carboxamide
CAS Number	695213-59-3 Y
PubChem CID	2227769
ChemSpider	1665835
Chemical and physical data
Formula	C21H24N2O
Molar mass	320.43 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(NCC1=CC=CC=C1)C2=CN(CCCCC)C3=CC=CC=C32

SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC₅₀ of 19 nM for human CB₂ receptors, and 134 nM for human CB₁ receptors.^[1] It was discovered during research into the related compound SDB-001 which had been sold illicitly as "2NE1".^[2]

See also

• 5F-CUMYL-PINACA
• 5F-SDB-006
• APINACA
• CUMYL-PICA
• CUMYL-PINACA
• CUMYL-THPINACA
• SDB-001
• SDB-005
• STS-135

References

1. ↑ Banister, S. D.; Stuart, J.; Kevin, R. C.; Edington, A.; Longworth, M.; Wilkinson, S. M.; Beinat, C.; Buchanan, A. S.; Hibbs, D. E.; Glass, M.; Connor, M.; McGregor, I. S.; Kassiou, M. (2015). "Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135". ACS Chemical Neuroscience. 6: 150508124201002. PMID 25921407. doi:10.1021/acschemneuro.5b00107. 
2. ↑ Banister, S. D.; Wilkinson, S. M.; Longworth, M.; Stuart, J.; Apetz, N.; English, K.; Brooker, L.; Goebel, C.; Hibbs, D. E.; Glass, M.; Connor, M.; McGregor, I. S.; Kassiou, M. (2013). "The synthesis and pharmacological evaluation of adamantane-derived indoles: Novel cannabimimetic drugs of abuse". ACS Chemical Neuroscience. 4 (7): 130403084729007. PMC 3715837 . PMID 23551277. doi:10.1021/cn400035r.